O6 Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least 7 days

• Inge De Lepeleire,
• Randolph P. Matthews,
• Dirk Schürmann,
• Deanne J. Rudd,
• Vanessa Levine,
• Sabrina Fox-Bosetti,
• Sandra Zhang,
• Martine Robberechts,
• Andreas Hüser,
• DariaJ Hazuda,
• JayA Grobler,
• Aubrey Stoch,
• Marian Iwamoto

Affiliations

Inge De Lepeleire

MSD, Kenilworth, NJ, USA and Brussels, Belgium

Randolph P. Matthews

MSD, Kenilworth, NJ, USA and Brussels, Belgium

Dirk Schürmann

Charité Research Organisation, Berlin, Germany

Deanne J. Rudd

MSD, Kenilworth, NJ, USA and Brussels, Belgium

Vanessa Levine

MSD, Kenilworth, NJ, USA and Brussels, Belgium

Sabrina Fox-Bosetti

MSD, Kenilworth, NJ, USA and Brussels, Belgium

Sandra Zhang

MSD, Kenilworth, NJ, USA and Brussels, Belgium

Martine Robberechts

MSD, Kenilworth, NJ, USA and Brussels, Belgium

Andreas Hüser

Charité Research Organisation, Berlin, Germany

DariaJ Hazuda

MSD, Kenilworth, NJ, USA and Brussels, Belgium

JayA Grobler

MSD, Kenilworth, NJ, USA and Brussels, Belgium

Aubrey Stoch

MSD, Kenilworth, NJ, USA and Brussels, Belgium

Marian Iwamoto

MSD, Kenilworth, NJ, USA and Brussels, Belgium